Hospital-based collaboration for epidemiological investigation of vaccine safety: A potential solution for low and middle-income countries?
Vaccine
.
2018 Jan 8;36(3):345-346.
doi: 10.1016/j.vaccine.2017.10.003.
Epub 2017 Oct 21.
Authors
Hector S Izurieta
1
,
Pedro L Moro
2
,
Robert T Chen
3
Affiliations
1
Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, MD, USA. Electronic address: Hector.Izurieta@fda.hhs.gov.
2
Immunization Safety Office (ISO), Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
3
Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
PMID:
29033065
PMCID:
PMC6524777
DOI:
10.1016/j.vaccine.2017.10.003
No abstract available
Publication types
Editorial
Comment
MeSH terms
Developing Countries
Humans
Measles*
Meningitis, Aseptic*
Mumps*
Pharmacovigilance
Purpura, Thrombocytopenic, Idiopathic*
Vaccination
Vaccines*
Substances
Vaccines
Grants and funding
CC999999/Intramural CDC HHS/United States